- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Clinical Trials on 심근 허혈, 협심증 in Korea, Democratic People's Republic of
총 640 건
-
Seoul National University HospitalLudwig-Maximilians - University of Munich; ST. Antonius hospital Nieuwegein모병
-
Seoul National University HospitalBoston Scientific Korea Co. Ltd; Dio; Terumo Corporation; Abbott알려지지 않은
-
Seoul National University Hospital완전한
-
Seung-Jung ParkCardioVascular Research Foundation, Korea모병
-
Sejong General HospitalKeimyung University Dongsan Medical Center; Soon Chun Hyang University; Hanyang University...모병
-
KangWon National University HospitalThe Korean Society of Cardiology완전한
-
Chong Kun Dang PharmaceuticalInje University완전한
-
Hanmi Pharmaceutical Company Limited완전한최소 6개월 동안 DAPT(클로피도그렐 + 아스피린)를 필요로 하는 급성 관상동맥 증후군 또는 B 뇌경색대한민국
-
Samsung Medical CenterChonnam National University모집하지 않고 적극적으로
-
Korea University Anam Hospital완전한
-
Inje UniversitySamsung Medical Center; Seoul National University Hospital; Ulsan University Hospital; Keimyung... 그리고 다른 협력자들완전한
-
Soonchunhyang University HospitalBoston Scientific Corporation; The Catholic University of Korea; Eulji University; Hanil General...모병
-
Sejong General HospitalSeoul St. Mary's Hospital; Pusan National University Hospital; Ulsan University Hospital; Seoul... 그리고 다른 협력자들모병
-
Genoss Co., Ltd.모병
-
Seung-Jung ParkRoche Pharma AG; AstraZeneca; KBM pharm완전한
-
Seung-Jung ParkCardioVascular Research Foundation, Korea완전한
-
Seung-Jung ParkCardioVascular Research Foundation, Korea모집하지 않고 적극적으로관상 동맥 질환 | 경피 경혈관 관상동맥 성형술대한민국
-
Yonsei University모병차세대 DES 이식으로 관상동맥 재생술이 필요한 관상동맥 질환대한민국
-
CHEOL WHAN LEE, M.D., Ph.D완전한
-
Seoul National University Hospital모병
-
Hanyang University Seoul HospitalAbbott; Soon Chun Hyang University완전한관상동맥 질환 | 급성관상동맥증후군 | 경피적 관상동맥 중재술대한민국
-
Seoul National University Bundang Hospital알려지지 않은
-
Samsung Medical Center모병
-
Yonsei UniversityKorean Society of Lipidology and Atherosclerosis알려지지 않은
-
Pusan National University Yangsan HospitalAstraZeneca알려지지 않은
-
Yonsei UniversityChong Kun Dang Pharmaceutical Corp.알려지지 않은관상동맥 질환 | 관상동맥경화증 | 하이드록시메틸글루타릴-CoA 환원효소 억제제대한민국
-
Yonsei University알려지지 않은
-
Yonsei University완전한OPCAB 시행 예정인 급성관상동맥증후군 환자 총 234명.대한민국
-
Genoss Co., Ltd.모병급성관상동맥증후군 | 경피적 관상동맥 중재술 | 이중 항혈소판 요법대한민국
-
Hanyang University Seoul HospitalHanyang University모병
-
Yuhan Corporation완전한급성관상동맥증후군 | 염증을 동반한 경동맥 죽상경화반대한민국
-
Yonsei UniversityTerumo Corporation모집하지 않고 적극적으로
-
Seoul National University Bundang HospitalThe Korean Society of Lipidology and Atherosclerosis완전한
-
Tehran University of Medical Sciences모병
-
Yonsei UniversitySeverance Hospital; Genoss Co., Ltd.모병
-
Yonsei UniversityBoston Scientific Corporation; Severance Hospital완전한
-
Gyeongsang National University Hospital완전한
-
Genoss Co., Ltd.모병
-
Gyeongsang National University Hospital완전한
-
Samsung Medical CenterChonnam National University Hospital; Chosun University Hospital; Gangneung Asan Hospital모집하지 않고 적극적으로
-
Yonsei UniversityMedtronic; Severance Hospital모병
-
Seoul National University HospitalInje University완전한
-
Seoul National University HospitalSamsung Medical Center; Ulsan University Hospital; Stanford University; Inje University; Royal... 그리고 다른 협력자들알려지지 않은